Kowa company founded as the Hattori Kanesaburo Wholesale Store
About Us
Our history
As part of the Kowa family of companies, we have more than 100 years of experience in business we can call upon and we are proud of our Japanese influence and heritage. Our experience not only encompasses pharmaceutical medicine development and marketing but also development of medical devices as well as experience in construction, the leisure industry, energy conservation and the environment.
Pharmaceutical division is established
Construction of the new main office building of Kowa Spinning Co., Ltd. was completed.
Tokyo research laboratory and Fuji manufacturing plant founded
Hamamatsu Medical equipment manufacturing site built
Livalo (Pitavastatin) for the treatment of dyslipidemia launched in Japan
Glanatec® (ripasudil) launched in Japan, first-in-class rho kinase inhibitor for the treatment of glaucoma and ocular hypertension.
Kowa Pharmaceutical Asia Pte. Ltd. Established in Singapore.
Parmodia® (pemafibrate) for the treatment of hyperlipidemia launched in Japan.
Founded in 1894, Kowa Company, Ltd. commemorated the 125th anniversary of the foundation on December 25, 2019.
Livalo® (pitavastatin) for the treatment of dyslipidemia launched in Singapore.
Glanatec® (ripasudil) launched in Singapore, first-in-class rho kinase inhibitor for the treatment of glaucoma and ocular hypertension.
Parmodia® (pemafibrate) for the treatment of dyslipidemia characterized by high TG launched in Singapore.
